Capricor Therapeutics Inc. (4LN2)
FSX
Real-time Data
06:00 AM
Day's Range
6.9352 wk Range
2.58Overview - 4LN2 - Capricor Therapeutics Inc.
Key Statistics
Valuation
Enterprise Value
175.44M
P/E (Trailing)
‪-3.06‬
P/E (Forward)
‪-7.29‬
PEG Ratio
‪-0.27‬
Price / Book
‪1.91‬
EV / EBITDA
‪-1.53‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-33.63%‬
Return on Equity
‪-73.70%‬
Ownership
Shares Outstanding
57.66M
Float
45.54M
Held by Insiders
‪9.43%‬
Held by Institutions
‪76.06%‬
Price stats
Beta
‪0.52‬
50-Day Avg
‪13.46‬
200-Day Avg
‪19.86‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 4LN2 - Capricor Therapeutics Inc.
Peers - 4LN2 - Capricor Therapeutics Inc.
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- 4LN2FSXCapricor Therapeutics Inc.313.95MMarket Cap-9.63%52-week change-2.39P/E (Trailing)‪0.00%‬Profit Margin
- ANLFSXAnalog Devices, Inc.155.08BMarket Cap+30.19%52-week change43.54P/E (Trailing)‪29.78%‬Profit Margin
- 1AEFSXargenx SE56.27BMarket Cap+30.57%52-week change39.07P/E (Trailing)‪32.26%‬Profit Margin
- 1AEAFSXargenx SE American Depositary Receipt54.72BMarket Cap+33.14%52-week change39.13P/E (Trailing)‪32.26%‬Profit Margin
- 0QFFSXModerna, Inc.47.69BMarket Cap+84.54%52-week change25.27P/E (Trailing)‪-141.42%‬Profit Margin
- 42ZFSXRevolution Medicines Inc.37.93BMarket Cap+83.17%52-week change-30.35P/E (Trailing)‪0.00%‬Profit Margin
- 49BAFSXBeOne Medicines, Ltd. American Depositary Receipt35.29BMarket Cap+16.03%52-week change65.41P/E (Trailing)‪10.69%‬Profit Margin
Profile Summary - 4LN2 - Capricor Therapeutics Inc.
About
Capricor Therapeutics Inc. is a clinical-stage biotechnology company focused on developing transformative cell and exosome-based therapeutics for rare diseases with high unmet medical needs, particularly Duchenne muscular dystrophy (DMD), which causes muscle degeneration and premature death. Its lead product…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
